Genmab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish ...

A groundbreaking lung cancer vaccine will be tested on humans from summer 2026, with British scientists working on jabs for ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

New clinical evidence indicates that a widely used supplement may alter gut microbes involved in vitamin D biology and ...

CureVac and the University of Texas’s MD Anderson Cancer Center have announced a co-development and licensing agreement to develop novel messenger ribonucleic acid (mRNA)-based cancer vaccines. The ...

Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung ...

Despite advances, cancer drug development success rates remain low. GSK is employing innovative technologies to overcome this challenge By Hesham Abdullah, MD, MSc, Senior Vice President, Global Head ...

Most cancer genome studies have focused on mutations in the tumor itself and how such gene variants allow a tumor to grow unchecked. A new study, led by researchers at Washington University School of ...

You're five times more likely to contract bowel cancer if two particular factors are present, a groundbreaking new Australian research study has found. Bowel cancer, or colorectal cancer, is currently ...

The Adult Drug Development Unit (DDU) at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, comprises an internationally-leading group of >100 staff focused on early ...

White individuals are more likely to be diagnosed with cancer compared to ethnic minorities, academics have reported. Academics from Cancer Research UK found that the number of cancer cases amongst ...